ISM
Laboratorios Farmaceuticos Rovi, S.a.
Application Filed: 2019-05-16
Trademark Application Details
NOTICE OF ALLOWANCE - ISSUED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88433098 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Kevin P. Hartley |
| Law Office Assigned | L90 |
| Employee Name | RATCLIFFE, ROBERT L |
Timeline
| 2019-05-16 | Application Filed |
| 2019-10-29 | Published for Opposition |
| 2019-12-24 | Location: INTENT TO USE SECTION |
| 2019-12-24 | Status: Live/Pending |
| 2019-12-24 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  LABORATORIOS FARMACEUTICOS ROVI, S.A. |
| Entity Statement | sociedad anonima (sa) |
| Address | C/ Julián Camarillo, n° 35 Madrid ES E-28037 |
| Legal Entity Type | |
| Legal Entity State | ES |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical implants and sustained release medical implants, namely, implantable subcutaneous and intramuscular drug delivery devices sold filled with pharmaceutical preparations for treatment of central nervous system diseases, schizophrenia, hormonal diseases, contraception, allergies, thrombosis, coagulation diseases, pain and inflammation, for the treatment of cancer; cartridges for medical purposes filled with noninjectable pharmaceutical products, namely, cartridges sold pre-filled with gases and gas mixtures for medical use; injectable cartridges and ampoules, namely, disposable syringes sold pre-filled with pharmaceutical preparations for treatment of central nervous system diseases, schizophrenia, hormonal diseases, contraception, allergies, thrombosis, coagulation diseases, pain and inflammation, for the treatment of cancer |
| GS0051 | Pharmaceutical implants and sustained release medical implants, namely, implantable subcutaneous and intramuscular drug delivery devices sold filled with pharmaceutical preparations for treatment of central nervous system diseases, schizophrenia, hormonal diseases, contraception, allergies, thrombosis, coagulation diseases, pain and inflammation, for the treatment of cancer |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2019-05-20 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-06-01 | 2 NWOS I:Incoming Correspondence |
| TEAS PETITION TO DIRECTOR-MAKE SPECIAL-RECEIVED | 2019-06-17 | 3 TPMS I:Incoming Correspondence |
| ASSIGNED TO PETITION STAFF | 2019-07-03 | 4 APET A:Allowance for Publication |
| PETITION TO DIRECTOR - MAKE SPECIAL - GRANTED | 2019-07-15 | 5 PMSG O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2019-07-15 | 6 DOCK D:Assigned to Examiner |
| ASSIGNED TO EXAMINER | 2019-07-16 | 7 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2019-07-23 | 8 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2019-07-23 | 9 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-07-23 | 10 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-08-24 | 11 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-08-24 | 12 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-08-26 | 13 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-09-20 | 14 CNSA P: |
| ASSIGNED TO LIE | 2019-09-25 | 15 ALIE A:Allowance for Publication |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-10-08 | 16 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-10-08 | 17 ARAA I:Incoming Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-10-09 | 18 NONP E:E-Mail |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2019-10-08 | 19 TCCA I:Incoming Correspondence |
| PUBLISHED FOR OPPOSITION | 2019-10-29 | 20 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-10-29 | 21 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-12-24 | 22 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2020-02-05 | 23 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2020-02-05 | 24 EXT1 S: |
| EXTENSION 1 GRANTED | 2020-02-05 | 25 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-02-07 | 26 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2020-10-26 | 27 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2020-10-26 | 28 EXT2 S: |
| EXTENSION 2 GRANTED | 2020-10-26 | 29 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-10-28 | 30 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2021-04-26 | 31 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2021-04-26 | 32 EXT3 S: |
| EXTENSION 3 GRANTED | 2021-04-26 | 33 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-04-28 | 34 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2021-09-15 | 35 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2021-09-15 | 36 EXT4 S: |
| EXTENSION 4 GRANTED | 2021-09-15 | 37 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-09-17 | 38 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2022-05-26 | 39 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2022-06-02 | 40 AITU A:Allowance for Publication |
| SOU EXTENSION 5 FILED | 2022-05-26 | 41 EXT5 S: |
| SOU EXTENSION 5 GRANTED | 2022-06-02 | 42 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-06-03 | 43 EXRA E:E-Mail |
| TEAS PETITION TO AMEND BASIS RECEIVED | 2022-12-20 | 44 TPAD I:Incoming Correspondence |
| TEAS POST PUBLICATION AMENDMENT RECEIVED | 2022-12-20 | 45 EPPA I:Incoming Correspondence |
| NOTICE OF ALLOWANCE CANCELLED | 2022-12-20 | 46 IUCN S: |
| ASSIGNED TO PETITION STAFF | 2023-01-17 | 47 APET A:Allowance for Publication |
| PETITION TO DIRECTOR - CHANGE BASIS - GRANTED | 2023-01-18 | 48 PCBG O:Outgoing Correspondence |
| JURISDICTION RESTORED TO EXAMINING ATTORNEY | 2023-01-18 | 49 JURT T:TTAB Proceeding |
| PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2023-01-31 | 50 ZZZX Z:Deletion |
| NON-FINAL ACTION WRITTEN | 2023-02-04 | 51 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2023-02-04 | 52 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2023-02-04 | 53 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-02-14 | 54 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-02-14 | 55 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-02-15 | 56 TEME I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2023-04-04 | 57 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2023-04-04 | 58 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2023-04-04 | 59 GNFN O:Outgoing Correspondence |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2023-05-25 | 60 ERFR I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-05-25 | 61 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-05-25 | 62 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-07-01 | 63 CNSA O:Outgoing Correspondence |
| ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | 2023-07-07 | 64 ERRR O:Outgoing Correspondence |
| ELECTRONIC RECORD REVIEW COMPLETE | 2023-07-10 | 65 FIXD O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-07-26 | 66 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2023-08-15 | 67 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-08-15 | 68 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2023-10-31 | 69 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2023-10-31 | 70 NRCC E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 